Trends in annual number of ESRD incident cases, crude and standardized incidence rates of ESRD, and annual percentage change in the U.S. population, 1980-2016

Figure 1.1
Trends in the (a) crude and standardized incidence rates of ESRD, and (b) the annual percentage change in the standardized incidence rate of ESRD in the U.S. population, 1980-2016
(a) Incidence rate per million/year
Incidence rate per million/year
Data Source: Special analyses, USRDS ESRD Database. The special analyses exclude U.S. territories, unknown age, and unknown/other races. Standardized to the age-sex-race distribution of the 2011 U.S. population. Abbreviation: ESRD, end-stage renal disease.
(b) One-year percentage change in standardized incidence rate
One-year percentage change in standardized incidence rate
Data Source: Special analyses, USRDS ESRD Database. The special analyses exclude U.S. territories, unknown age, and unknown/other races. Standardized to the age-sex-race distribution of the 2011 U.S. population. Abbreviation: ESRD, end-stage renal disease.

Figure 1.2
Trends in the annual number of ESRD incident cases, by modality, in the U.S. population, 1980-2016
Trends in the annual number of ESRD incident cases, by modality, in the U.S. population, 1980-2016
Data Source: Reference Table D.1 and special analyses of USRDS ESRD Database. Persons with “Uncertain Dialysis” were included in the “All ESRD” total, but are not represented separately. Abbreviation: ESRD, end-stage renal disease.

Crude and standardized incidence rates of ESRD and annual number of ESRD incident cases, overall and by modality and ESRD Network (ordered from highest to lowest standardized rate), in the U.S. population, 2016

Figure 1.3
Map of the standardized incidence rate of ESRD, by Health Service Area, in the U.S. population, 2012-2016
Map of the standardized incidence rate of ESRD, by Health Service Area, in the U.S. population, 2012-2016
Data Source: Special analyses, USRDS ESRD Database. Standardized to the age-sex-race distribution of the 2011 U.S. population. Special analyses exclude unknown age, sex, HSA, and unknown/other race. Values for cells with 10 or fewer patients are suppressed. Abbreviation: ESRD, end-stage renal disease.

Figure 1.4
Trends in standardized ESRD incidence rate, by age group, in the U.S. population, 2000-2016
Trends in standardized ESRD incidence rate, by age group, in the U.S. population, 2000-2016
Data Source: Special analyses, USRDS ESRD Database. Standardized to the sex-race distribution of the 2011 U.S. population. Special analyses exclude unknown age, sex, and unknown/other race. Abbreviation: ESRD, end-stage renal disease.

Figure 1.5
Trends in standardized ESRD incidence rate, by race, in the U.S. population, 2000-2016
Trends in standardized ESRD incidence rate, by race, in the U.S. population, 2000-2016
Data Source: Special analyses, USRDS ESRD Database. Standardized to the age-sex distribution of the 2011 U.S. population. Special analyses exclude unknown age, sex, and unknown/other race. Abbreviations: Af Am, African American; AI/AN: American Indian/Alaska Native; ESRD, end-stage renal disease.

Figure 1.6
Trends in standardized ESRD incidence rate, by Hispanic ethnicity, in the U.S. population, 2000-2016
Trends in standardized ESRD incidence rate, by Hispanic ethnicity, in the U.S. population, 2000-2016
Data Source: Special analyses, USRDS ESRD Database. Standardized to the age-sex-race distribution of the 2011 U.S. population. Special analyses exclude unknown age, sex, and unknown/other race. Abbreviation: ESRD, end-stage renal disease.

Figure 1.7
Cumulative incidence (%) of ESRD from birth to age 100+, by race/ethnicity, in the U.S. (a) male and (b) female populations, 2013
(a) Male Population
Male Population
Source: Albertus et al. (Am J Kidney Dis, 2016). Abbreviation: ESRD, end-stage renal disease.
(b) Female population
Female population
Source: Albertus et al. (Am J Kidney Dis, 2016). Abbreviation: ESRD, end-stage renal disease.

Male population
Female population

Trends in annual number of ESRD prevalent cases, crude and standardized ESRD prevalence, and annual percentage changes, in the U.S. population, 1980-2016

Figure 1.8
Trends in the (a) crude and standardized prevalence of ESRD, and (b) annual percentage change in the standardized prevalence of ESRD, in the U.S. population, 1980-2016
(a) Prevalence per million
Prevalence per million
Data Source: Special analyses, USRDS ESRD Database. The special analyses exclude U.S. territories, unknown age, and unknown/other races. Standardized for age, sex, and race. Abbreviation: ESRD, end-stage renal disease.
(b) One-year percentage change in standardized prevalence
One-year percentage change in standardized prevalence
Data Source: Special analyses, USRDS ESRD Database. The special analyses exclude U.S. territories, unknown age, and unknown/other races. Standardized for age, sex, and race. Abbreviation: ESRD, end-stage renal disease.

Figure 1.9
Trends in the number of ESRD prevalent cases, by modality, in the U.S. population,1980-2016
Trends in the number of ESRD prevalent cases, by modality, in the U.S. population,1980-2016
Data Source: Reference Table D.1 and special analyses, USRDS ESRD Database. Persons with “Uncertain Dialysis” were included in the “All ESRD” total, but are not represented separately. Abbreviation: ESRD, end-stage renal disease.

Crude and standardized* prevalence of ESRD (per million) and annual number of ESRD prevalent cases, overall and by modality (hemodialysis, peritoneal dialysis, and transplantation) and ESRD Network (ordered from highest to lowest standardized rate), in the U.S. population, 2016

Figure 1.10
Map of the standardized prevalence of ESRD, by Health Service Area, in the U.S. population, 2012-2016*
Map of the standardized prevalence of ESRD, by Health Service Area, in the U.S. population, 2012-2016*
Data Source: Special analyses, USRDS ESRD Database. Standardized to the age-sex-race distribution of the 2011 U.S. population. Special analyses exclude unknown age, sex, HSA, and unknown/other race. *Four Health Service Areas were suppressed because the ratio of crude rate to standardized rate or standardized rate to crude rate was greater than 3. Values for cells with 10 or fewer patients are suppressed. Abbreviation: ESRD, end-stage renal disease.

Figure 1.11
Trends in the standardized prevalence of ESRD, by age group, in the U.S. population, 2000-2016
Trends in the standardized prevalence of ESRD, by age group, in the U.S. population, 2000-2016
Data Source: Special analyses, USRDS ESRD Database. Point prevalence on December 31 of each year. Standardized to the sex-race distribution of the 2011 U.S. population. Special analyses exclude unknown age, sex, and unknown/other race. Abbreviation: ESRD, end-stage renal disease.

Figure 1.12
Trends in the standardized prevalence of ESRD, by race, in the U.S. population, 2000-2016
Trends in the standardized prevalence of ESRD, by race, in the U.S. population, 2000-2016
Data Source: Special analyses, USRDS ESRD Database. Point prevalence on December 31 of each year. Standardized to the age-sex distribution of the 2011 U.S. population. Special analyses exclude unknown age, sex, and unknown/other race. Abbreviations: Af Am, African American; AI/AN: American Indian/Alaska Native; ESRD, end-stage renal disease; NH/PI: Native Hawaiian/Pacific Islander.

Figure 1.13
Trends in the standardized prevalence of ESRD, by Hispanic ethnicity, in the U.S. population, 2000-2016
Trends in the standardized prevalence of ESRD, by Hispanic ethnicity, in the U.S. population, 2000-2016
Data Source: Special analyses, USRDS ESRD Database. Point prevalence on December 31 of each year. Standardized to the age-sex-race distribution of the 2011 U.S. population. Special analyses exclude unknown age, sex, and unknown/other race. Abbreviation: ESRD, end-stage renal disease.

Figure 1.14
Trends in the number of incident ESRD cases using home dialysis, by type of therapy, in the U.S. population, 1996-2016
Trends in the number of incident ESRD cases using home dialysis, by type of therapy, in the U.S. population, 1996-2016
Data Source: Reference Table D.1 and special analyses, USRDS ESRD Database. Abbreviation: ESRD, end-stage renal disease.

Number and percentage of incident ESRD patients receiving hemodialysis (HD), peritoneal dialysis (PD), and a transplant, by age, sex, race, ethnicity, and primary cause of ESRD, in the U.S. population, 2016

Figure 1.15
Map of the percentage of incident dialysis cases using home dialysis (peritoneal dialysis or home hemodialysis), by Health Service Area, 2012-2016
Map of the percentage of incident dialysis cases using home dialysis (peritoneal dialysis or home hemodialysis), by Health Service Area, 2012-2016
Data Source: Special analyses, USRDS ESRD Database. Values for cells with 10 or fewer patients are suppressed. Abbreviation: ESRD, end-stage renal disease.

Figure 1.16
Trends in number of prevalent ESRD cases using home dialysis, by type of therapy, in the United States, 1996-2016
Trends in number of prevalent ESRD cases using home dialysis, by type of therapy, in the United States, 1996-2016
Data Source: Reference Table D.1. December 31 prevalent ESRD patients. Peritoneal dialysis consists of continuous ambulatory peritoneal dialysis (CAPD), continuous cycling peritoneal dialysis (CCPD), and intermittent peritoneal dialysis (other PD) only. Abbreviation: ESRD, end-stage renal disease.

Number and percentage of prevalent ESRD patients receiving hemodialysis, peritoneal dialysis, and a transplant, by age, sex, race, ethnicity, and the primary cause of ESRD, in the United States, 2016

Figure 1.17
Map of the percentage of prevalent dialysis cases using home dialysis, by Health Service Area, 2012-2016
Map of the percentage of prevalent dialysis cases using home dialysis, by Health Service Area, 2012-2016
Data Source: Special analyses, USRDS ESRD Database. Values for cells with 10 or fewer patients are suppressed. Abbreviation: ESRD, end-stage renal disease.

Demographic characteristics (% with row)
Clinical characteristics (% with row)

Figure 1.18
Map of the percentage of incident cases who had received >12 months of pre-ESRD nephrology care, by Health Service Area, 2012-2016
Map of the percentage of incident cases who had received >12 months of pre-ESRD nephrology care, by Health Service Area, 2012-2016
Data Source: Special analyses, USRDS ESRD Database. Population only includes incident cases with the form CMS 2728. Values for cells with 10 or fewer patients are suppressed. Abbreviations: ESRD, end-stage renal disease; Neph, nephrology.

Figure 1.19
Trends in the distribution of eGFR (ml/min/1.73 m2) among incident ESRD patients, 1996-2016
Trends in the distribution of eGFR (ml/min/1.73 m<sup>2</sup>) among incident ESRD patients, 1996-2016
Data Source: Special analyses, USRDS ESRD Database. Population only includes incident cases with the form CMS 2728. eGFR calculated using the CKD-EPI equation (CKD-EPI eGFR (ml/min/1.73 m2)) for those aged ≥18 and the Schwartz equation for those aged <18. Abbreviations: CKD-EPI; chronic kidney disease epidemiology calculation; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease.

Distributions of laboratory values (mean) and treatment characteristics (%), by age, sex, race, ethnicity, and the primary cause of ESRD, among incident ESRD cases, 2016

Figure 1.20
Map of mean eGFR at initiation of renal replacement therapy, by Health Service Area, 2012-2016
Map of mean eGFR at initiation of renal replacement therapy, by Health Service Area, 2012-2016
Data Source: Special analyses, USRDS ESRD Database. Population only includes incident cases with the form CMS 2728. eGFR calculated using the CKD-EPI equation (CKD-EPI eGFR (ml/min/1.73 m2)) for those aged ≥18 and the Schwartz equation for those aged <18. Values for cells with 10 or fewer patients are suppressed. Abbreviations: CKD-EPI, chronic kidney disease epidemiology calculation; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease.

Figure 1.21
Map of mean hemoglobin level at initiation of renal replacement therapy, by Health Service Area, 2012-2016
Map of mean hemoglobin level at initiation of renal replacement therapy, by Health Service Area, 2012-2016
Data Source: Special analyses, USRDS ESRD Database. Population only includes incident cases with the form CMS 2728. Values for cells with 10 or fewer patients are suppressed. Abbreviations: ESRD, end-stage renal disease; Hgb, hemoglobin.

Distribution of duration of pre-ESRD nephrology care (in %), mean hemoglobin level, and mean eGFR, by ESRD Network, among incident ESRD cases in the U.S. population, 2016